Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: Pfizer 15.034, Merck & Co. 16.607.
Pfizer vs Merck & Co.: Revenue Comparison
Pfizer (PFE) and Merck & Co. (MRK) are peers in GLP-1. Pfizer reported revenue of $15.0B as of Q2 2026, compared with $16.6B for Merck & Co.. Merck & Co. leads on revenue.
Pfizer's gross margin is 72.8% versus 73.5% for Merck & Co.. Pfizer's net margin is -1.6% versus -8.0% for Merck & Co..
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Pfizer, Merck & Co..| Metric | Pfizer | Merck & Co. |
|---|---|---|
| Market Cap | - | - |
| Revenue | $15.03B | $16.61B |
| Cost of Revenue | $4.09B | $4.39B |
| Gross Profit | $10.94B | $12.21B |
| Operating Income | $4.71B | $-683.00M |
| Net Income | $-246.00M | $-1.33B |
| R&D Expense | $2.81B | $9.74B |
| Earnings Per Share | -$0.04 | -$0.54 |
| Gross Margin | 72.8% | 73.5% |
| Operating Margin | 31.3% | -4.1% |
| Net Profit Margin | -1.6% | -8.0% |
| Free Cash Flow | $302.00M | $4.48B |
| Cumulative Free Cash Flow | $356.70B | $249.70B |
| Operating Cash Flow | $835.00M | $5.37B |
| Cash & Equivalents | $976.00M | $6.85B |